Elmore Patent Law Group, P.C.
Spiropyrrolidine derived antiviral agents
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, thereof: which inhibit coronavirus replication activity. The invention further relates to pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof, and methods of treating or preventing a coronavirus infection in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of Formula (I) or a pharmaceutically acceptable salt thereof. 
Enanta Pharmaceuticals, Inc.
C A
C07D A61P
inventional inventional
Jorden Ruichao Jiajun Wei Guoqiang Hui Xuri Xiaowen Yat Sun
Kass Shen Zhang Li Wang Cao Gao Peng Or